Albany Molecular Research, Inc. Company Profile

05:14 EDT 6th July 2015 | BioPortfolio

Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. For over 22 years AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in North America, Europe and Asia now provide our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development.
AMRI’s services include Contract Research (Discovery), Development and Contract Manufacturing including Aseptic Fill and Finish. Since 1991, AMRI has steadily expanded and globalized its contract services platform beyond its major U.S. facilities through a combination of acquisitions and green field initiatives, which include:

  • process development and large scale manufacturing in the UK;
  • custom library synthesis, medicinal chemistry, chemical development and cGMP scale up and manufacturing in India;
  • medicinal chemistry and in vitro biology in Singapore;
  • aseptic fill and finish capabilities in Burlington, Massachusetts. 

AMRI provides a broad range of services and technologies to provide flexible and strategic support for discovery and development of pharmaceutical products and the manufacturing of API and drug product for existing and experimental new drugs, providing geographic proximity and creative budgetary solutions. 

AMRI is also investing in a small number of discovery programs with the intention to partner promising technology, a high value added service having resulted in five clinical candidates and licensing partnerships with Bristol-Myers Squibb, Genentech and Bessor Pharma.

Location

26 Corporate Circle
Albany
New York
12203
United States of America

Contact

Phone: (518) 512-2000
Fax: (518) 512-2020
Email: info@amriglobal.com


News Articles [767 Associated News Articles listed on BioPortfolio]

Albany Molecular Research management update

Albany IVF has joined the world renowned Boston IVF fertility network and will now be known as Boston IVF – The Albany Center.

Albany, NY (PRWEB) March 17, 2015 Albany IVF has joined the world renowned Boston IVF fertility network and will now be known as Boston IVF – The Albany Center. Internationally recognized f...

AMRI to acquire Aptuit businesses units for $60 million

US-based drug development and discovery company Aptuit has divested its aseptic clinical manufacturing site in Glasgow, UK, to US contract research organization Albany Molecular Research, said Aptuit...

Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Albany Molecular Research, Inc. and Lead Plaintiff Deadline of January 12, 2015

NEW YORK, Jan. 9, 2015 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed in the United States District...

AMRI to Present at Jefferies 2015 Healthcare Conference

ALBANY, N.Y., May 20, 2015 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at ...

AMRI to shutter U.K. facility, lay off 62 workers

Albany Molecular Research (AMRI), a global contract research and manufacturing organization, has decided to close its Holywell, U.K., facility, which provides chemical development services and small- ...

AMRI, HarkerBIO collaborate

Albany Molecular Research (AMRI), a CRO based in Albany, N.Y., has signed a collaborative agreement with Buffalo, N.Y.-based biotechnology company HarkerBIO to co-market their structure-based drug di...

AMRI to Present at the Bank of America Merrill Lynch 2015 Health Care Conference

ALBANY, N.Y., May 1, 2015 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at the Bank of...

PubMed Articles [2997 Associated PubMed Articles listed on BioPortfolio]

Harnessing the crowd to accelerate molecular medicine research.

Crowdsourcing presents a novel approach to solving complex problems within molecular medicine. By leveraging the expertise of fellow scientists across the globe, broadcasting to and engaging the publi...

Applying the community partnership approach to human biology research.

Contemporary human biology research employs a unique skillset for biocultural analysis. This skillset is highly appropriate for the study of health disparities because disparities result from the inte...

The Story of MCF-7 Breast Cancer Cell Line: 40 years of Experience in Research.

Breast cancer is the most frequent malignancy in females. Due to its major impact on population, this disease represents a critical public health problem that requires further research at the molecula...

Synchrotron-Based and Globar-Sourced Molecular (Micro)spectroscopy Contributions to Advances in New Hulless Barley (with Structure Alteration) Research on Molecular Structure, Molecular Nutrition and Nutrient Delivery.

This article aimed to review synchrotron-based and globar-sourced molecular infrared (micro)spectroscopy contributions to advances in new hulless barley (with structure alteration) research on molecul...

Quantitative Single-Cell Approaches to Stem Cell Research.

Understanding the molecular control of cell fates is central to stem cell research. Such insight requires quantification of molecular and cellular behavior at the single-cell level. Recent advances no...

Clinical Trials [1222 Associated Clinical Trials listed on BioPortfolio]

Acute Technical Outcomes of the Talent Abdominal Aortic Aneurysm (AAA) Stent-Graft Versus Cook Zenith Stent-Graft

The purpose of this study is to compare acute technical outcomes of the Talent AAA Stent Graft system versus Cook Zenith Endograft at two high volume institutions, Albany Medical Center an...

Biopsies of Cancer Patients for Tumor Molecular Characterization

In this research study, we are looking at performing a repeat biopsy of patients' tumors, even though they have already been diagnosed with cancer. The tumor tissue obtained from the biop...

Genetic Analysis of Liver Cancer

Liver cancer is a leading cause of cancer deaths worldwide. While the molecular pathogenesis of liver cancer has been extensively studied, less is known about how the molecular biology of ...

IMPACT 2: Randomized Study Evaluating Molecular Profiling and Targeted Agents in Metastatic Cancer

The goal of this research study is to compare the effects of treatment based on molecular profiling to those of the standard-of-care. Treatment Assignment: From a tumor biopsy, a m...

Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer

RATIONALE: Using samples of blood, urine, sputum, and tissue from patients at high risk of cancer for laboratory studies may help doctors learn more about changes that may occur in DNA and...

Companies [1812 Associated Companies listed on BioPortfolio]

Albany Molecular Research Incorporated

Founded in 1991, Albany Molecular Research, Inc. is a chemistry company with a core nucleus of accomplished scientists who have extensive experience within the pharmaceutical industry. Albany Molecula...

Albany Molecular Research, Inc. (AMRI)

Albany Molecular Research, Inc.

Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. For o...

Albany College of Pharmacy and Health Sciences

Founded in 1881, Albany College of Pharmacy and Health Sciences is a private, independent institution committed to the advancement of health. The College has academic programs and research activities ...

AMRI

Founded in 1991, Albany Molecular Research, Inc. provides scientific services, products and technologies focused on improving the quality of life. AMRI works on drug discovery and...

More Information about "Albany Molecular Research, Inc." on BioPortfolio

We have published hundreds of Albany Molecular Research, Inc. news stories on BioPortfolio along with dozens of Albany Molecular Research, Inc. Clinical Trials and PubMed Articles about Albany Molecular Research, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Albany Molecular Research, Inc. Companies in our database. You can also find out about relevant Albany Molecular Research, Inc. Drugs and Medications on this site too.


Advertisement
 

Relevant Topics

Pharmacy
Latest News Clinical Trials Research Drugs Reports Corporate
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Latest News Clinical Trials Research Drugs Reports Corporate
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology
Latest News Clinical Trials Research Drugs Reports Corporate
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record